Oct 22, 2026 08:00AM
Oct 12, 2026 08:00AM
Oct 12, 2026 08:00AM
Oct 6, 2026 08:00AM
Oct 5, 2026 07:00AM
Oct 5, 2026 07:00AM
Sep 23, 2026 04:02PM Stoke Therapeutics adds Bo Cumbo to its board of directors
Sep 23, 2026 04:01PM
Sep 10, 2026 04:57AM
Sep 4, 2026 06:00AM
Sep 3, 2026 07:30PM
Sep 1, 2026 07:30AM
Sep 1, 2026 07:30AM
Aug 5, 2026 08:00AM Stoke Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
Aug 3, 2026 04:01PM
Jul 27, 2026 04:01PM
Jul 13, 2026 07:30AM
Jul 13, 2026 07:30AM
Jun 30, 2026 08:01AM
Jun 30, 2026 08:00AM
May 28, 2026 04:01PM Stoke Therapeutics to Present at Upcoming Investor Conferences in June
May 7, 2026 04:01PM
Apr 30, 2026 04:01PM
Apr 8, 2026 04:01PM
Apr 8, 2026 09:15AM
Apr 7, 2026 04:01PM
Apr 7, 2026 04:01PM
Mar 20, 2026 06:58AM Stoke Therapeutics (STOK) PT Raised to $60 at Canaccord
Mar 4, 2026 05:05PM
Feb 24, 2026 04:01PM
Feb 11, 2026 07:30AM
Feb 11, 2026 07:30AM
Feb 4, 2026 04:01PM
Jan 12, 2026 07:45AM
Jan 11, 2026 02:00PM Stoke Therapeutics accelerates Phase 3 trial timeline for Dravet drug
Jan 11, 2026 02:00PM
Jan 5, 2026 04:34AM
Dec 5, 2025 09:01AM
Dec 5, 2025 09:00AM
Dec 5, 2025 09:00AM
Dec 1, 2025 07:31AM
Dec 1, 2025 07:30AM Stoke Therapeutics and Biogen Announce Presentations at the 2025 American Epilepsy Society Annual Meeting
Nov 4, 2025 04:01PM
Oct 20, 2025 07:30AM
Oct 13, 2025 01:34PM
Oct 9, 2025 04:31PM
Oct 9, 2025 04:30PM
Oct 9, 2025 04:30PM
Sep 2, 2025 07:03AM Biogen and Stoke present three-year zorevunersen data for Dravet syndrome
Sep 2, 2025 07:01AM

335,242 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All